Erythroid progenitors from patients with low-risk myelodysplastic syndromes are dependent on the surrounding micro environment for their survival

被引:1
|
作者
Folkerts, Hendrik [1 ]
Hazenberg, Carin L. E. [1 ]
Houwerzijl, Ewout J. [2 ]
van den Heuvel, Fiona A. J. [1 ,3 ]
Mulder, Andre B. [3 ]
van der Want, Johannes J. L. [4 ,5 ]
Vellenga, Edo [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9700 RB Groningen, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9700 RB Groningen, Netherlands
[5] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway
关键词
BONE-MARROW; ENHANCED AUTOPHAGY; STEM-CELL; MEGAKARYOCYTES; PRECURSORS; HEMATON;
D O I
10.1016/j.exphem.2014.11.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate whether the type of programmed cell death of myelodysplastic erythroid cells depends on their cellular context, we performed studies on cells from patients with low-risk myelodysplastic syndromes. We compared erythroid cells (and their precursor cells) from the mononuclear cell fraction with those from the hematon fraction, which are compacted complexes of hematopoietic cells surrounded by their own micro-environment. In directly fixed materials, erythroblasts exhibited signs of autophagy with limited apoptosis (<3%) based on ultrastructural characteristics and immunogold labeling for activated caspase-3. After 24 h in culture, myelodysplastic erythroblasts exhibited a significant increase in apoptosis (22 +/- 7% vs. 3 +/- 2%, p = 0.001). In contrast, the myelodysplastic erythroblasts from the hematon fraction did not exhibit an increased tendency toward apoptosis after culture (7 +/- 3.3% vs. 1.8 +/- 2.3%), which was in line with results for normal bone marrow cells. The same dependency on the micro-environment was noted for immature erythroid progenitor cells. Myelodysplastic hematons exhibited distinct numbers of erythroid burst-forming units in association with an extensive network of stromal cells, whereas small numbers of erythroid burst-forming units were generated from the myelodysplastic mononuclear cells compared with normal mononuclear cells (10.2 +/- 9 vs. 162 +/- 125, p < 0.001). Co-culture of erythroid myelodysplastic cells in the presence of growth factors (vascular endothelial growth factor, leukemia inhibitory factor) or on the MS-5 stromal layer did not restore the expansion of erythroid precursor cells. These data indicate that surviving myelodysplastic erythroid progenitors become more vulnerable to programmed cell death when they are detached from their own micro-environment. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:215 / 222
页数:8
相关论文
共 11 条
  • [1] High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes
    Riabov, Vladimir
    Mossner, Maximilian
    Stoehr, Alexandra
    Jann, Johann-Christoph
    Streuer, Alexander
    Schmitt, Nanni
    Knaflic, Antje
    Nowak, Verena
    Weimer, Nadine
    Oblaender, Julia
    Palme, Iris
    Schumann, Christiane
    Baldus, Claudia D.
    Schulze, Torsten J.
    Wuchter, Patrick
    Roehl, Henning
    Jawhar, Ahmed
    Weiss, Christel
    Boch, Tobias
    Metzgeroth, Georgia
    Neumann, Martin
    Hofmann, Wolf-Karsten
    Nolte, Florian
    Nowak, Daniel
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (05) : 879 - 891
  • [2] The Different Immunoregulatory Functions of Mesenchymal Stem Cells in Patients with Low-Risk or High-Risk Myelodysplastic Syndromes
    Zhao, Zhigang
    Wang, Zhenling
    Li, Qiubai
    Li, Weiming
    You, Yong
    Zou, Ping
    PLOS ONE, 2012, 7 (09):
  • [3] Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria
    Houwerzijl, E. J.
    Pol, H-W D.
    Blom, N. R.
    van der Want, J. J. L.
    de Wolf, J. Thm
    Vellenga, E.
    LEUKEMIA, 2009, 23 (05) : 886 - 891
  • [4] Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation
    van Leeuwen-Kerkhoff, Nathalie
    Westers, Theresia M.
    Poddighe, Pino J.
    de Gruijl, Tanja D.
    Kordasti, Shahram
    van de Loosdrecht, Arjan A.
    HAEMATOLOGICA, 2020, 105 (04) : 961 - 970
  • [5] Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
    Wu, Yuenv
    Aanei, Carmen Mariana
    Kesr, Sanae
    Picot, Tiphanie
    Guyotat, Denis
    Catafal, Lydia Campos
    FRONTIERS IN ONCOLOGY, 2017, 7 : 164
  • [6] Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes
    Sand, Kristoffer
    Theorell, Jakob
    Bruserud, Oystein
    Bryceson, Yenan T.
    Kittang, Astrid Olsnes
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (09) : 1135 - 1147
  • [7] Evaluation of VEGF and VEGFR gene expression as prognostic markers in low and intermediate-1 risk patients with myelodysplastic syndromes
    Kalitin, Nikolay
    Dudina, Galina
    Kostritsa, Natalia
    Sivirinova, Anastasiya
    Karamysheva, Aida
    ONCOLOGY LETTERS, 2023, 25 (03)
  • [8] CD34-Positive Blast Count and p53 Expression in Bone Marrow Biopsies of Patients with Low-Risk Myelodysplastic Syndromes: Potential Predictive Tools of Response to Erythropoietin Stimulating Agents
    Boggio, Francesca
    Del Gobbo, Alessandro
    Barella, Marco
    Croci, Giorgio
    Cassin, Ramona
    Reda, Gianluigi
    Pettine, Loredana
    Bandiera, Laura
    Bonoldi, Emanuela
    Riva, Marta
    Gianelli, Umberto
    PATHOBIOLOGY, 2021, 88 (03) : 242 - 250
  • [9] Over-Expression of Cancerous Inhibitor of PP2A (CIP2A) in Bone Marrow Cells from Patients with a Group of High-Risk Myelodysplastic Syndromes
    Li, Na
    Abe, Shinya
    Kurata, Morito
    Abe-Suzuki, Shiho
    Onishi, Iichiroh
    Kirimura, Susumu
    Murayama, Toshihiko
    Hidaka, Michihiro
    Kawano, Fumio
    Kitagawa, Masanobu
    PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (02) : 399 - 407
  • [10] Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34+ cells selected from patients with both low- and high-risk myelodysplastic syndrome
    Gueller, Saskia
    Komor, Martina
    Nowak, Daniel
    Baldus, Claudia D.
    de Vos, Sven
    Hoelzer, Dieter
    Ottmann, Oliver G.
    Holmann, Wolf-K.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : 718 - 732